The expansion adds 8,075 square feet of state-of-the-art GMP manufacturing space to the San Diego biologics manufacturing ...

Trump signed an Executive Order (EO) titled “Regulatory Relief Critical Medicines.” The order’s goal is to strengthen the U.S. pharmaceutical supply chain by streamlining regulatory processes, ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today plans to invest more than $700 million ...

Shamekh SIV Solutions, LLC announced their $5.8 billion global plan for a series of pharmaceutical manufacturing facilities aligned with the executive order signed by President Trump on May 5, 2025, ...

Greentech and Roche are planning domestic manufacturing facilities, adding to the list of projects sparked by Trump's push ...

Its CGMP-compliant facilities include multiple scales ... Digital Twins in Pharmaceutical and Biopharmaceutical Manufacturing: A Literature Review. Processes 2020; 8(9), 1088.

SHANGHAI - Swiss pharmaceutical giant Roche has announced plans to invest 2.04 billion yuan ($283 million) in building a new ...

Genentech has announced plans to invest more than $700 million in a new 700,000 square foot drug manufacturing facility.

South Korea's government pledged more support measures on Wednesday for key export industries, including the ...

Swiss pharmaceutical giant Roche has announced plans to invest 2.04 billion yuan in building a new biopharmaceutical manufacturing facility in ...